MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Comparison of motor and non-motor symptoms in operated and medically treated dystonia patients

A. Maurer, U. Hidding, W. Hamel, C. Moll, C. Gerloff, M. Gelderblom, S. Zittel-Dirks (Hamburg, Germany)

Meeting: 2019 International Congress

Abstract Number: 1312

Keywords: Deep brain stimulation (DBS), Dystonia: Clinical features, Dystonia: Treatment

Session Information

Date: Tuesday, September 24, 2019

Session Title: Dystonia

Session Time: 1:45pm-3:15pm

Location: Les Muses Terrace, Level 3

Objective: To evaluate motor and psychiatric symptoms as well as quality of life (QoL) in dystonia patients treated with botulinumtoxin/medication (non-DBS group) and deep brain stimulation (DBS) (DBS group) in a monocentric dystonia cohort.

Background: Dystonia is a movement disorder characterized by sustained or intermittent muscle contractions leading to abnormal postures or movements. Psychiatric comorbidities, e.g. depression and anxiety disorders frequently accompany motor symptoms and QoL may be impaired.

Method: 63 patients were enrolled in the study. Motor symptom severity was assessed with the Global Dystonia Rating Scale (GDRS) and the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS). Psychiatric symptoms were evaluated with the Hospital Anxiety and Depression Scale (HADS-D), Beck Depression Inventory II (BDI-II), Liebowitz Social Anxiety Scale (LSAS) and the Patient Health Questionnaire 9 (PHQ-9). Quality of life was investigated with the Short Form 36 Questionnaire (SF-36).

Results: Patients in the DBS group were more severely affected by motor symptoms than patients in the non-DBS group (GDRS p = 0.023, BFMDRS p = 0.001)(Table 1). Depression and anxiety were overall frequent comorbidities, but there was no significant difference between groups (depression and anxiety frequency in non-DBS/DBS group: HADS-D 67%/67%, BDI-II 34%/29%, LSAS 50%/53%, PHQ-9 65%58%) (Table 2). QoL was impaired affecting all sub-items of the SF-36, but was not different between groups (figure 1).

Conclusion: Although patients in the DBS group had more severe motor symptoms than the non-DBS patients, there were no differences in the frequency of psychiatric symptoms and QoL impairment. Depression and anxiety had a high prevalence in our cohort, confirming results of previous studies. Our findings highlight the importance of treating not only motor but also non-motor symptoms in dystonia patients. The study was supported by the Dystract Consortium.

Table 1. Demographic data and motor scores

Table 2. Psychiatric Scores

Figure 1. Quality of life

To cite this abstract in AMA style:

A. Maurer, U. Hidding, W. Hamel, C. Moll, C. Gerloff, M. Gelderblom, S. Zittel-Dirks. Comparison of motor and non-motor symptoms in operated and medically treated dystonia patients [abstract]. Mov Disord. 2019; 34 (suppl 2). https://www.mdsabstracts.org/abstract/comparison-of-motor-and-non-motor-symptoms-in-operated-and-medically-treated-dystonia-patients/. Accessed May 15, 2025.
  • Tweet
  • Email
  • Print

« Back to 2019 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/comparison-of-motor-and-non-motor-symptoms-in-operated-and-medically-treated-dystonia-patients/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • #26133 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley